285 related articles for article (PubMed ID: 28458303)
1. Prognostic Impact of Indocyanine Green Plasma Disappearance Rate in Hepatocellular Carcinoma Patients after Radiofrequency Ablation: A Prognostic Nomogram Study.
Azumi M; Suda T; Terai S; Akazawa K
Intern Med; 2017; 56(9):1001-1007. PubMed ID: 28458303
[TBL] [Abstract][Full Text] [Related]
2. Nomograms to Predict the Disease-free Survival and Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma.
Takuma Y; Shota I; Miyatake H; Uematsu S; Okamoto R; Araki Y; Takabatake H; Morimoto Y; Yamamoto H
Intern Med; 2018 Feb; 57(4):457-468. PubMed ID: 29151504
[TBL] [Abstract][Full Text] [Related]
3. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
Lee S; Rhim H; Kim YS; Kang TW; Song KD
Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Percutaneous Thermal Ablation Combined With Transarterial Embolization for Recurrent Hepatocellular Carcinoma After Hepatectomy and a Prognostic Nomogram to Predict Survival.
Yuan Z; Wang Y; Hu C; Gao W; Zheng J; Li W
Technol Cancer Res Treat; 2018 Jan; 17():1533033818801362. PubMed ID: 30244651
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation.
Kim CG; Lee HW; Choi HJ; Lee JI; Lee HW; Kim SU; Park JY; Kim DY; Ahn SH; Han KH; Kim HS; Kim KH; Choi SJ; Kim Y; Lee KS; Kim GM; Kim MD; Won JY; Lee DY; Kim BK
Cancer Med; 2019 Sep; 8(11):5023-5032. PubMed ID: 31290618
[TBL] [Abstract][Full Text] [Related]
6. A Patient-Based Nomogram for Predicting Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma.
Lee S; Han S; Shim JH; Kim SY; Won HJ; Shin YM; Kim PN; An J; Lee D; Kim KM; Lim YS; Chung YH; Lee YS; Lee HC
J Vasc Interv Radiol; 2015 Dec; 26(12):1787-94.e1. PubMed ID: 26542708
[TBL] [Abstract][Full Text] [Related]
7. A novel nomogram to predict the local tumor progression after microwave ablation in patients with early-stage hepatocellular carcinoma: A tool in prediction of successful ablation.
An C; Wu S; Huang Z; Ni J; Zuo M; Gu Y; Zhang T; Huang J
Cancer Med; 2020 Jan; 9(1):104-115. PubMed ID: 31714685
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Nomogram for Patients with Hepatocellular Carcinoma After Thermal Ablation.
Ding M; Zhao X; Zhao M; Shi Y; Wang T; Cui D; Shi D; Zhai B
Cardiovasc Intervent Radiol; 2020 Nov; 43(11):1621-1630. PubMed ID: 32814990
[TBL] [Abstract][Full Text] [Related]
9. A novel nomogram for prediction of intrahepatic recurrence-free survival in patients with HCC followed by radiofrequency ablation.
Wang B; Wu H; Wang S; Zhang ZY; Wu W; Yan K; Yang W
Br J Radiol; 2024 Mar; 97(1156):844-849. PubMed ID: 38346708
[TBL] [Abstract][Full Text] [Related]
10. Survival outcome of salvage hepatectomy in patients with local, recurrent hepatocellular carcinoma who underwent radiofrequency ablation as their first treatment.
Ueno M; Nakai T; Hayashi M; Hirokawa F; Nagano H; Wada H; Kaibori M; Matsui K; Tanaka S; Yamaue H; Kubo S
Surgery; 2016 Sep; 160(3):661-70. PubMed ID: 27267547
[TBL] [Abstract][Full Text] [Related]
11. Prognostic nomogram for hepatocellular carcinoma with radiofrequency ablation: a retrospective cohort study.
Lu Z; Sun Z; Liu C; Shi X; Li R; Shao W; Zheng Y; Li Y; Song J
BMC Cancer; 2021 Jun; 21(1):751. PubMed ID: 34187430
[TBL] [Abstract][Full Text] [Related]
12. Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
Xu L; Peng ZW; Chen MS; Shi M; Zhang YJ; Guo RP; Lin XJ; Lau WY
J Hepatol; 2015 Jul; 63(1):122-30. PubMed ID: 25725438
[TBL] [Abstract][Full Text] [Related]
13. Long-term Favorable Outcomes of Radiofrequency Ablation for Hepatocellular Carcinoma as an Initial Treatment: A Single-center Experience Over a 10-Year Period.
Tsukamoto M; Yamashita YI; Imai K; Umezaki N; Yamao T; Kaida T; Mima K; Nakagawa S; Hashimoto D; Chikamoto A; Ishiko T; Baba H
Anticancer Res; 2018 Feb; 38(2):1047-1052. PubMed ID: 29374739
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
[TBL] [Abstract][Full Text] [Related]
15. When to Perform Surgical Resection or Radiofrequency Ablation for Early Hepatocellular Carcinoma?: A Nomogram-guided Treatment Strategy.
Liu PH; Hsu CY; Lee YH; Hsia CY; Huang YH; Su CW; Chiou YY; Lin HC; Huo TI
Medicine (Baltimore); 2015 Oct; 94(43):e1808. PubMed ID: 26512576
[TBL] [Abstract][Full Text] [Related]
16. Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma.
Wan G; Gao F; Chen J; Li Y; Geng M; Sun L; Liu Y; Liu H; Yang X; Wang R; Feng Y; Wang X
BMC Cancer; 2017 Jan; 17(1):91. PubMed ID: 28143427
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors for survival in patients with hepatocellular carcinoma after radiofrequency ablation].
Lee JH; Han SY; Jo JH; Kim SK; Go BS; Oh JY; Choi JC; Lee SW; Jang JS; Roh MH
Korean J Gastroenterol; 2007 Jan; 49(1):17-23. PubMed ID: 18167429
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular Carcinoma: Nomograms Based on the Albumin-Bilirubin Grade to Assess the Outcomes of Radiofrequency Ablation.
Kao WY; Su CW; Chiou YY; Chiu NC; Liu CA; Fang KC; Huo TI; Huang YH; Chang CC; Hou MC; Lin HC; Wu JC
Radiology; 2017 Nov; 285(2):670-680. PubMed ID: 28562211
[TBL] [Abstract][Full Text] [Related]
19. High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma.
Kobayashi M; Ikeda K; Kawamura Y; Yatsuji H; Hosaka T; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Kumada H
Cancer; 2009 Feb; 115(3):571-80. PubMed ID: 19117347
[TBL] [Abstract][Full Text] [Related]
20. Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma.
Feng LH; Dong H; Lau WY; Yu H; Zhu YY; Zhao Y; Lin YX; Chen J; Wu MC; Cong WM
J Cancer Res Clin Oncol; 2017 Feb; 143(2):293-303. PubMed ID: 27743138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
